High neutralizing antibody titer in intensive care unit patients with COVID-19
High neutralizing antibody titer in intensive care unit patients with COVID-19
About this item
Full title
Author / Creator
Publisher
United States: Taylor & Francis
Journal title
Language
English
Formats
Publication information
Publisher
United States: Taylor & Francis
Subjects
More information
Scope and Contents
Contents
Coronavirus disease 2019 (COVID-19) has a wide spectrum of disease severity from mild upper respiratory symptoms to respiratory failure. The role of neutralizing antibody (NAb) response in disease progression remains elusive. This study determined the seroprevalence of 733 non-COVID-19 individuals from April 2018 to February 2020 in the Hong Kong S...
Alternative Titles
Full title
High neutralizing antibody titer in intensive care unit patients with COVID-19
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_3efabe15847a40bbb810a09d99037efc
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3efabe15847a40bbb810a09d99037efc
Other Identifiers
ISSN
2222-1751
E-ISSN
2222-1751
DOI
10.1080/22221751.2020.1791738
